Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Radiation Research
|
January 14, 2020
Concentration ratios of 238U and 226Ra for insects and amphibians living in the vicinity of the closed uranium mine at Ningyo-toge, Japan
Akihiro Sakoda, Shoichi Murakami, Yuu Ishimori, et al.
Journal of the American Chemical Society
|
September 26, 2023
<i>N</i>-Heterocyclic Carbenes with Polyfluorinated Groups at the 4- and 5-Positions from [3 + 2] Cycloadditions between Formamidinates and <i>cis</i>-1,2-Difluoroalkene Derivatives
Masato Ohashi, Kota Ando, Shoichi Murakami, et al.
Optics Express
|
March 18, 2026
Channel-selective frequency up-conversion for frequency-multiplexed quantum network
Shoichi Murakami, Shunsuke Hiraoka, Toshiki Kobayashi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2005
A proof of the specificity of kanamycin-ribosomal RNA interaction with designed synthetic analogs and the antibacterial activity
Yoshio Nishimura, Hayamitsu Adachi, Motoki Kyo, et al.
Environmental Monitoring and Assessment
|
May 10, 2022
Environmental monitoring of trace elements and evaluation of environmental impacts to organisms near a former uranium mining site in Nigyo-toge, Japan
Sawako Horai, Shoichi Murakami, Akihiro Sakoda, et al.
Experimental Animals
|
February 2, 2012
Evaluation of four antiseptics using a novel murine norovirus
Takashi Matsuhira, Chizuko Kaji, Shoichi Murakami, et al.
Bioorganic & Medicinal Chemistry
|
November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity
Dai Kubota, Minoru Ishikawa, Mikio Yamamoto, et al.
Bioorganic & Medicinal Chemistry
|
November 26, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility
Minoru Ishikawa, Yukiko Hiraiwa, Dai Kubota, et al.
The Journal of Antibiotics
|
June 29, 2017
Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity
Yoshiaki Takahashi, Eijiro Umemura, Yoshihiko Kobayashi, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 2006
Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitution
Dai Kubota, Minoru Ishikawa, Midori Ishikawa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Radiation Research
|
January 14, 2020
Concentration ratios of 238U and 226Ra for insects and amphibians living in the vicinity of the closed uranium mine at Ningyo-toge, Japan
Akihiro Sakoda, Shoichi Murakami, Yuu Ishimori, et al.
Journal of the American Chemical Society
|
September 26, 2023
<i>N</i>-Heterocyclic Carbenes with Polyfluorinated Groups at the 4- and 5-Positions from [3 + 2] Cycloadditions between Formamidinates and <i>cis</i>-1,2-Difluoroalkene Derivatives
Masato Ohashi, Kota Ando, Shoichi Murakami, et al.
Optics Express
|
March 18, 2026
Channel-selective frequency up-conversion for frequency-multiplexed quantum network
Shoichi Murakami, Shunsuke Hiraoka, Toshiki Kobayashi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2005
A proof of the specificity of kanamycin-ribosomal RNA interaction with designed synthetic analogs and the antibacterial activity
Yoshio Nishimura, Hayamitsu Adachi, Motoki Kyo, et al.
Environmental Monitoring and Assessment
|
May 10, 2022
Environmental monitoring of trace elements and evaluation of environmental impacts to organisms near a former uranium mining site in Nigyo-toge, Japan
Sawako Horai, Shoichi Murakami, Akihiro Sakoda, et al.
Experimental Animals
|
February 2, 2012
Evaluation of four antiseptics using a novel murine norovirus
Takashi Matsuhira, Chizuko Kaji, Shoichi Murakami, et al.
Bioorganic & Medicinal Chemistry
|
November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity
Dai Kubota, Minoru Ishikawa, Mikio Yamamoto, et al.
Bioorganic & Medicinal Chemistry
|
November 26, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility
Minoru Ishikawa, Yukiko Hiraiwa, Dai Kubota, et al.
The Journal of Antibiotics
|
June 29, 2017
Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity
Yoshiaki Takahashi, Eijiro Umemura, Yoshihiko Kobayashi, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 2006
Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitution
Dai Kubota, Minoru Ishikawa, Midori Ishikawa, et al.
Page
of 2